Year: 2022

DFW Capital Partners Exits Children’s Dental Management

For Immediate Release January 12, 2022 Teaneck, NJ DFW Capital Partners successfully exits its investment in Children’s Dental Management DFW Capital Partners (“DFW”) is pleased to announce that it has completed the sale of its portfolio company, CDHA Holdings, LLC (“Children’s Dental Management”, “CDM” or the “Company”). CDM is the largest pediatric specialist-led dental support… Read more »

Amneal Acquires Saol Therapeutics’ Baclofen Franchise

BRIDGEWATER, N.J. & ROSWELL, Ga.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics, a private specialty pharmaceutical company (“Saol”), today announced a definitive agreement under which Amneal will acquire Saol’s Baclofen franchise, including Lioresal® and LYVISPAHTM as well as a pipeline product under development. The acquisition expands Amneal’s commercial institutional and specialty portfolio in neurology while… Read more »